GeneTune
01 / The story
Tirzepatide acts at both GIP and GLP-1 receptors. The original GeneTune slides use two pathways to make that difference easier to remember.
02 / In plain language
01
Signal one
GLP-1 receptor activity is part of the appetite and glucose-regulation story.
02
Signal two
GIP receptor activity adds a second incretin route.
03
The distinction
Two receptor targets describe its mechanism; clinical outcomes depend on the studied population and indication.
THE IDEA TO KEEPTwo receptors are a mechanism, not a shortcut to predicting results.
03 / Where the evidence stops
Regulatory label + clinical evidence
The FDA prescribing information identifies tirzepatide as a GIP and GLP-1 receptor agonist. The slides below are selected frames from the original post.